Compliance news, white papers, reports, and events from PharmaLeaders. New content daily, on our website and delivered right to your inbox.

FDA Holds Final GDUFA III Meeting With Industry

GDUFA III will need to be enacted by Congress in order to take effect at the start of fiscal 2023, which begins on Oct. 1, 2022.

MSL Teams Need to Digitize, or Face Being Left Behind

Medical Science Liaisons (MSL) in the pharma industry were already at their limit pre-COVID. The challenge for MSLs is to identify the most efficient way to upskill their teams and add digital competencies without overloading them.

UK Clamps Down on Lack of Transparency in Trials

One of the most important obligations for researchers seeking UK clinical trial approval is to determine from the start how they will disseminate their study results publicly.

Five Ways Study Sites Benefit from Remote Monitoring

Authored and contributed to PharmaLeaders by Jeff Pool, VP of Revenue at Florence Healthcare Failed remote site access and monitoring attempts have left study sites with a computer full of access portals, FTP logins, document vaults, and emails. Why do sponsor remote site access and monitoring rollouts fail? Because the sponsor focuses on solving their access problems ...

Whitepaper: Execute a 5-Step Framework for Data Compliance in Healthcare Marketing in the 2020s

The 2020s will transform how consumers and businesses interact with each other as vast amounts of personal and contextually relevant data will be generated. These changes will demand organizations implement a new framework for deploying and managing communications, for implementing innovative omnichannel marketing strategies and tools, and for acquiring and utilizing data. This whitepaper explains how to ...

Healthcare Marketing Trends for 2019 Emphasize Better Targeting with Cost-Effective Advantages

As healthcare marketers strive to keep pace with data technologies for better targeting and conversion, budgeting for 2019 becomes a formidable challenge. Questions about competitive advantages and cost-effectiveness drive conversations. Yet, the focus of forward-thinkers is shifting to better data for targeting faster and sooner in the engagement lifecycle. “We are seeing a dramatic increase in ...